(Q24236598)

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

A placebo-controlled crossover trial of creatine in mitochondrial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Beneficial effects of creatine supplementation in dystrophic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Effects of resistance exercise and creatine supplementation on myasthenia gravis: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Effect of Creatine and Weight Training on Muscle Creatine and Performance in Vegetarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Resistance training exercise and creatine in patients with Charcot-Marie-Tooth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Effect of creatine ingestion after exercise on muscle thickness in males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine supplementation combined with resistance training in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine supplementation during college football training does not increase the incidence of cramping or injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Few adverse effects of long-term creatine supplementation in a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Exploring the therapeutic role of creatine supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine for treating muscle disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Single- and multiple-dose pharmacokinetics of oral creatine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Long-term oral creatine supplementation does not impair renal function in healthy athletes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Adverse effects of creatine supplementation: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Effect of oral creatine supplementation on urinary methylamine, formaldehyde, and formate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Drug treatment for facioscapulohumeral muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Risk assessment for creatine monohydrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

A clinical trial of creatine in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine monohydrate increases strength in patients with neuromuscular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine transporter and mitochondrial creatine kinase protein content in myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Dietary supplement creatine protects against traumatic brain injury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Neuroprotective effects of creatine administration against NMDA and malonate toxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Phosphocreatinine in myotonic dystrophy (Steinert's disease)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

The therapeutic potential of oral creatine supplementation in muscle disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Long-term creatine supplementation does not significantly affect clinical markers of health in athletes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Muscle creatine loading in men.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Creatine and creatinine metabolism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021

Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004760.PUB3

7 January 2021